Outset Medical (Outset Medical) Change In Receivables : $-2.4 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Outset Medical Change In Receivables?

Outset Medical's change in receivables for the quarter that ended in Mar. 2024 was $-3.5 Mil. It means Outset Medical's Accounts Receivable increased by $3.5 Mil from Dec. 2023 to Mar. 2024 .

Outset Medical's change in receivables for the fiscal year that ended in Dec. 2023 was $-5.1 Mil. It means Outset Medical's Accounts Receivable increased by $5.1 Mil from Dec. 2022 to Dec. 2023 .

Outset Medical's Accounts Receivable for the quarter that ended in Mar. 2024 was $36.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Outset Medical's Days Sales Outstanding for the three months ended in Mar. 2024 was 118.17.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Outset Medical's liquidation value for the three months ended in Mar. 2024 was $29.2 Mil.

Outset Medical Change In Receivables Historical Data

The historical data trend for Outset Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Outset Medical Change In Receivables Chart

Outset Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-2.89

-2.57

-19.14

-2.51

-5.09

Outset Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-6.22	-2.70	1.36	2.47	-3.50

Outset Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.4 Mil.

Outset Medical (NAS:OM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Outset Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	36.478	/	28.168	*	91
=	118.17

2. In Ben Graham's calculation of liquidation value, Outset Medical's accounts receivable are only considered to be worth 75% of book value:

Outset Medical's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	226.919	-	253.042	+	0.75 * 36.478	+	0.5 * 55.839
=	29.2

Outset Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Outset Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Outset Medical (Outset Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Outset Medical Inc (NAS:OM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

3052 Orchard Drive, San Jose, CA, USA, 95134

Website

https://www.outsetmedical.com

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Executives

Leslie Trigg	director, officer: President & CEO	C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Marc Nash	officer: SVP, Operations and R&D	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Jean-olivier Racine	officer: Chief Technology Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Nabeel Ahmed	officer: Interim CFO	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Stacey L. Porter	officer: Chief People Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
John L. Brottem	officer: General Counsel	3052 ORCHARD DR., SAN JOSE CA 95134
Steven S. Williamson	officer: Chief Commercial Officer	C/O HOLOGIC, INC., BEDFORD MA 01730
Martin Vazquez	officer: Chief Operating Officer	3052 ORCHARD DR., SAN JOSE CA 95134
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Dale E Jones	director	C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801
D Keith Grossman	director
Rebecca Chambers	officer: Chief Financial Officer	3052 ORCHARD DR., SAN JOSE CA 95134
Catherine M. Szyman	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Warburg Pincus Llc	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus X, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017